# Abaloparatide ACTIVE trial: vertebral fractures at 18 months

Source: https://pepvault.app/research/abaloparatide-active-2016

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Abaloparatide](https://pepvault.app/research#abaloparatide)

Randomized trial · people

# Abaloparatide: fewer new vertebral fractures vs placebo in ACTIVE

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In a large phase 3 trial, abaloparatide cut new spine and nonvertebral fractures compared with placebo and caused high blood calcium less often than teriparatide.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 2463
- **Published:** 2016
- **Journal:** JAMA

## What they tested

The team tested whether daily abaloparatide prevents new vertebral (spine bone) fractures better than placebo in postmenopausal women at risk of osteoporotic fractures, and how safe it is.

## How the study was done

A phase 3, double-blind, randomized trial at 28 sites in 10 countries in 2463 postmenopausal women with low bone density, mean age 69. For 18 months they took a daily shot under the skin of placebo (a dummy shot), abaloparatide in the 80 μg arm, or teriparatide in the 20 μg arm, which was open-label, meaning everyone knew they were getting it.

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

New vertebral fractures seen on X-ray were less common in both active drug groups than with placebo. The estimated rate of nonvertebral fractures was lower with abaloparatide than with placebo. Bone mineral density (BMD) at the total hip, femoral neck and lumbar spine rose more with abaloparatide than with placebo. Hypercalcemia (high blood calcium) occurred in 3.4% of women on abaloparatide vs 6.4% on teriparatide (risk difference −2.96, 95% CI −5.12 to −0.87).

## What it doesn’t show

The study included only postmenopausal women and lasted 18 months, and 1901 of the 2463 women completed it. The main test compared abaloparatide with placebo; the teriparatide arm was not blinded, so this was not a full head-to-head efficacy test against other osteoporosis drugs.

## The paper

Miller et al. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial. JAMA. 2016.

- [PubMed (PMID 27533157)](https://pubmed.ncbi.nlm.nih.gov/27533157/)
- [The paper (DOI 10.1001/jama.2016.11136)](https://doi.org/10.1001/jama.2016.11136)
- [ClinicalTrials.gov (NCT01343004)](https://clinicaltrials.gov/study/NCT01343004)

## The compound

- [Abaloparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

## With this study

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Open-label](https://pepvault.app/glossary/open-label)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

## More studies on Abaloparatide

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025) Meta-analysis · people · 2025
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) Meta-analysis · people · 2023
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024) Randomized trial · people · 2024
- [Abaloparatide improved hip geometry vs placebo in ACTIVE-J](https://pepvault.app/research/abaloparatide-active-j-2023) Randomized trial · people · 2023
- [Abaloparatide then alendronate: 84% lower vertebral fracture risk](https://pepvault.app/research/abaloparatide-activextend-2018) Randomized trial · people · 2018
- [Abaloparatide: normal bone biopsies after up to 18 months in ACTIVE](https://pepvault.app/research/abaloparatide-active-2017) Randomized trial · people · 2017
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Open-label](https://pepvault.app/glossary/open-label)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

## The library

- [Abaloparatide](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
